Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 41(40): 8279-8296, 2021 10 06.
Article in English | MEDLINE | ID: mdl-34413209

ABSTRACT

Experience-dependent formation and removal of inhibitory synapses are essential throughout life. For instance, GABAergic synapses are removed to facilitate learning, and strong excitatory activity is accompanied by the formation of inhibitory synapses to maintain coordination between excitation and inhibition. We recently discovered that active dendrites trigger the growth of inhibitory synapses via CB1 receptor-mediated endocannabinoid signaling, but the underlying mechanism remained unclear. Using two-photon microscopy to monitor the formation of individual inhibitory boutons in hippocampal organotypic slices from mice (both sexes), we found that CB1 receptor activation mediated the formation of inhibitory boutons and promoted their subsequent stabilization. Inhibitory bouton formation did not require neuronal activity and was independent of Gi/o-protein signaling, but was directly induced by elevating cAMP levels using forskolin and by activating Gs-proteins using DREADDs. Blocking PKA activity prevented CB1 receptor-mediated inhibitory bouton formation. Our findings reveal that axonal CB1 receptors signal via unconventional downstream pathways and that inhibitory bouton formation is triggered by an increase in axonal cAMP levels. Our results demonstrate an unexpected role for axonal CB1 receptors in axon-specific, and context-dependent, inhibitory synapse formation.SIGNIFICANCE STATEMENT Coordination between excitation and inhibition is required for proper brain function throughout life. It was previously shown that new inhibitory synapses can be formed in response to strong excitation to maintain this coordination, and this was mediated by endocannabinoid signaling via CB1 receptors. As activation of CB1 receptors generally results in the suppression of synaptic transmission, it remained unclear how CB1 receptors can mediate the formation of inhibitory synapses. Here we show that CB1 receptors on inhibitory axons signal via unconventional intracellular pathways and that inhibitory bouton formation is triggered by an increase in axonal cAMP levels and requires PKA activity. Our findings point to a central role for axonal cAMP signaling in activity-dependent inhibitory synapse formation.


Subject(s)
Axons/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic AMP/metabolism , Neural Inhibition/physiology , Presynaptic Terminals/metabolism , Receptor, Cannabinoid, CB1/metabolism , Animals , Axons/chemistry , Cyclic AMP/genetics , Cyclic AMP-Dependent Protein Kinases/genetics , Female , Hippocampus/chemistry , Hippocampus/metabolism , Male , Mice , Mice, Transgenic , Microscopy, Fluorescence, Multiphoton/methods , Organ Culture Techniques , Presynaptic Terminals/chemistry , Receptor, Cannabinoid, CB1/genetics , Time-Lapse Imaging/methods
2.
J Alzheimers Dis Rep ; 5(1): 153-160, 2021 Feb 27.
Article in English | MEDLINE | ID: mdl-33981952

ABSTRACT

The amyloid-ß protein precursor is highly expressed in a subset of inhibitory neuron in the hippocampus, and inhibitory neurons have been suggested to play an important role in early Alzheimer's disease plaque load. Here we investigated bouton dynamics in axons of hippocampal interneurons in two independent amyloidosis models. Short-term (24 h) amyloid-ß (Aß)-oligomer application to organotypic hippocampal slices slightly increased inhibitory bouton dynamics, but bouton density and dynamics were unchanged in hippocampus slices of young-adult App NL - F - G -mice, in which Aß levels are chronically elevated. These results indicate that loss or defective adaptation of inhibitory synapses are not a major contribution to Aß-induced hyperexcitability.

3.
J Alzheimers Dis ; 78(3): 951-964, 2020.
Article in English | MEDLINE | ID: mdl-33074225

ABSTRACT

BACKGROUND: In an early stage of Alzheimer's disease (AD), before the formation of amyloid plaques, neuronal network hyperactivity has been reported in both patients and animal models. This suggests an underlying disturbance of the balance between excitation and inhibition. Several studies have highlighted the role of somatic inhibition in early AD, while less is known about dendritic inhibition. OBJECTIVE: In this study we investigated how inhibitory synaptic currents are affected by elevated Aß levels. METHODS: We performed whole-cell patch clamp recordings of CA1 pyramidal neurons in organotypic hippocampal slice cultures after treatment with Aß-oligomers and in hippocampal brain slices from AppNL-F-G mice (APP-KI). RESULTS: We found a reduction of spontaneous inhibitory postsynaptic currents (sIPSCs) in CA1 pyramidal neurons in organotypic slices after 24 h Aß treatment. sIPSCs with slow rise times were reduced, suggesting a specific loss of dendritic inhibitory inputs. As miniature IPSCs and synaptic density were unaffected, these results suggest a decrease in activity-dependent transmission after Aß treatment. We observed a similar, although weaker, reduction in sIPSCs in CA1 pyramidal neurons from APP-KI mice compared to control. When separated by sex, the strongest reduction in sIPSC frequency was found in slices from male APP-KI mice. Consistent with hyperexcitability in pyramidal cells, dendritically targeting interneurons received slightly more excitatory input. GABAergic action potentials had faster kinetics in APP-KI slices. CONCLUSION: Our results show that Aß affects dendritic inhibition via impaired action potential driven release, possibly due to altered kinetics of GABAergic action potentials. Reduced dendritic inhibition may contribute to neuronal hyperactivity in early AD.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Dendrites/metabolism , Inhibitory Postsynaptic Potentials/genetics , Peptide Fragments/metabolism , Pyramidal Cells/metabolism , Action Potentials/drug effects , Action Potentials/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/pharmacology , Amyloidosis , Animals , CA1 Region, Hippocampal/cytology , Dendrites/drug effects , Disease Models, Animal , Humans , Immunohistochemistry , Inhibitory Postsynaptic Potentials/drug effects , Mice , Mice, Transgenic , Microscopy, Confocal , Neural Inhibition/drug effects , Neural Inhibition/genetics , Patch-Clamp Techniques , Pyramidal Cells/drug effects
4.
Elife ; 92020 08 24.
Article in English | MEDLINE | ID: mdl-32831174

ABSTRACT

Previously, we showed that modulation of the energy barrier for synaptic vesicle fusion boosts release rates supralinearly (Schotten, 2015). Here we show that mouse hippocampal synapses employ this principle to trigger Ca2+-dependent vesicle release and post-tetanic potentiation (PTP). We assess energy barrier changes by fitting release kinetics in response to hypertonic sucrose. Mimicking activation of the C2A domain of the Ca2+-sensor Synaptotagmin-1 (Syt1), by adding a positive charge (Syt1D232N) or increasing its hydrophobicity (Syt14W), lowers the energy barrier. Removing Syt1 or impairing its release inhibitory function (Syt19Pro) increases spontaneous release without affecting the fusion barrier. Both phorbol esters and tetanic stimulation potentiate synaptic strength, and lower the energy barrier equally well in the presence and absence of Syt1. We propose a model where tetanic stimulation activates Syt1-independent mechanisms that lower the energy barrier and act additively with Syt1-dependent mechanisms to produce PTP by exerting multiplicative effects on release rates.


Subject(s)
Neuronal Plasticity/physiology , Synaptic Vesicles , Synaptotagmin I/metabolism , Animals , Calcium/metabolism , Cells, Cultured , Female , Hippocampus/cytology , Hippocampus/metabolism , Male , Membrane Fusion/physiology , Mice , Mice, Inbred C57BL , Rats , Rats, Wistar , Synaptic Vesicles/chemistry , Synaptic Vesicles/metabolism
5.
Mol Cell Neurosci ; 102: 103452, 2020 01.
Article in English | MEDLINE | ID: mdl-31794878

ABSTRACT

SNAP-25, one of the three SNARE-proteins responsible for synaptic release, can be phosphorylated by Protein Kinase C on Ser-187, close to the fusion pore. In neuroendocrine cells, this phosphorylation event potentiates vesicle recruitment into releasable pools, whereas the consequences of phosphorylation for synaptic release remain unclear. We mutated Ser-187 and expressed two mutants (S187C and S187E) in the context of the SNAP-25B-isoform in SNAP-25 knockout glutamatergic autaptic neurons. Whole-cell patch clamp recordings were performed to assess the effect of Ser-187 phosphorylation on synaptic transmission. Blocking phosphorylation by expressing the S187C mutant did not affect synapse density, basic evoked or spontaneous neurotransmission, the readily-releasable pool size or its Ca2+-independent or Ca2+-dependent replenishment. Furthermore, it did not affect the response to phorbol esters, which activate PKC. Expressing S187C in the context of the SNAP-25A isoform also did not affect synaptic transmission. Strikingly, the - potentially phosphomimetic - mutant S187E reduced spontaneous release and release probability, with the largest effect seen in the SNAP-25B isoform, showing that a negative charge in this position is detrimental for neurotransmission, in agreement with electrostatic fusion triggering. During the course of our experiments, we found that higher SNAP-25B expression levels led to decreased paired pulse potentiation, probably due to higher release probabilities. Under these conditions, the potentiation of evoked EPSCs by phorbol esters was followed by a persistent down-regulation, probably due to a ceiling effect. In conclusion, our results indicate that phosphorylation of Ser-187 in SNAP-25 is not involved in modulation of synaptic release by Ca2+ or phorbol esters.


Subject(s)
Calcium/metabolism , Excitatory Postsynaptic Potentials , Synaptosomal-Associated Protein 25/metabolism , Animals , Cells, Cultured , Mice , Mice, Inbred C57BL , Mutation , Neuronal Plasticity , Neurons/drug effects , Neurons/metabolism , Neurons/physiology , Phorbol Esters/pharmacology , Phosphorylation , Protein Kinase C/metabolism , Rats , Rats, Wistar , Serine/chemistry , Serine/genetics , Synaptosomal-Associated Protein 25/chemistry , Synaptosomal-Associated Protein 25/genetics
6.
Cell Rep ; 26(9): 2340-2352.e5, 2019 02 26.
Article in English | MEDLINE | ID: mdl-30811985

ABSTRACT

Information transfer across CNS synapses depends on the very low basal vesicle fusion rate and the ability to rapidly upregulate that rate upon Ca2+ influx. We show that local electrostatic repulsion participates in creating an energy barrier, which limits spontaneous synaptic transmission. The barrier amplitude is increased by negative charges and decreased by positive charges on the SNARE-complex surface. Strikingly, the effect of charges on the barrier is additive and this extends to evoked transmission, but with a shallower charge dependence. Action potential-driven synaptic release is equivalent to the abrupt addition of ∼35 positive charges to the fusion machine. Within an electrostatic model for triggering, the Ca2+ sensor synaptotagmin-1 contributes ∼18 charges by binding Ca2+, while also modulating the fusion barrier at rest. Thus, the energy barrier for synaptic vesicle fusion has a large electrostatic component, allowing synaptotagmin-1 to act as an electrostatic switch and modulator to trigger vesicle fusion.


Subject(s)
SNARE Proteins/chemistry , Synaptic Transmission , Synaptic Vesicles/metabolism , Animals , Cells, Cultured , Excitatory Postsynaptic Potentials , Female , Male , Membrane Fusion , Mice , Mice, Knockout , Models, Neurological , Static Electricity , Synaptotagmin I/physiology
7.
J Neurosci ; 36(47): 11865-11880, 2016 11 23.
Article in English | MEDLINE | ID: mdl-27881774

ABSTRACT

Whether interactions between synaptotagmin-1 (syt-1) and the soluble NSF attachment protein receptors (SNAREs) are required during neurotransmission is debated. We examined five SNAP-25 mutations designed to interfere with syt-1 interactions. One mutation, D51/E52/E55A, targeted negative charges within region II of the primary interface (Zhou et al., 2015); two mutations targeted region I (D166A and D166/E170A) and one mutation targeted both (D51/E52/E55/D166A). The final mutation (D186/D193A) targeted C-terminal residues not expected to interact with syt-1. An in vitro assay showed that the region I, region II, and region I+II (D51/E52/E55/D166A) mutants markedly reduced the attachment between syt-1 and t-SNARE-carrying vesicles in the absence of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]. In the presence of PI(4,5)P2, vesicle attachment was unaffected by mutation. When expressed in Snap-25-null mouse autaptic neurons, region I mutations reduced the size of the readily releasable pool of vesicles, whereas the region II mutation reduced vesicular release probability. Combining both in the D51/E52/E55/D166A mutation abrogated evoked release. These data point to a division of labor between region I (vesicle priming) and region II (evoked release). Spontaneous release was disinhibited by region I mutations and found to correlate with defective complexin (Cpx) clamping in an in vitro fusion assay, pointing to an interdependent role of synaptotagmin and Cpx in release clamping. Mutation in region II (D51/E52/E55A) also unclamped release, but this effect could be overcome by synaptotagmin overexpression, arguing against an obligatory role in clamping. We conclude that three synaptic release functions of syt-1, vesicle priming, spontaneous release clamping, and evoked release triggering, depend on direct SNARE complex interaction. SIGNIFICANCE STATEMENT: The function of synaptotagmin-1 (syt-1):soluble NSF attachment protein receptor (SNARE) interactions during neurotransmission remains unclear. We mutated SNAP-25 within the recently identified region I and region II of the primary synaptotagmin:SNARE interface. Using in vitro assays and rescue experiments in autaptic neurons, we show that interactions within region II of the primary interface are necessary for synchronized calcium-triggered release, whereas region I is involved in vesicle priming. Spontaneous release was disinhibited by region I mutation and found to correlate with defective complexin (Cpx) clamping in vitro, pointing to an interdependent role of synaptotagmin and Cpx in release clamping. Therefore, vesicle priming, clamping spontaneous release, and eliciting evoked release are three different functions of syt-1 that involve different interaction modes with the SNARE complex.


Subject(s)
Action Potentials/physiology , Signal Transduction/physiology , Synaptic Transmission/physiology , Synaptic Vesicles/physiology , Synaptosomal-Associated Protein 25/metabolism , Synaptotagmin I/metabolism , Animals , Binding Sites , Calcium Signaling/physiology , Female , Mice , Mice, Knockout , Mutagenesis, Site-Directed , Protein Binding , Structure-Activity Relationship , Synaptosomal-Associated Protein 25/genetics , Synaptotagmin I/genetics
9.
Elife ; 4: e05531, 2015 Apr 14.
Article in English | MEDLINE | ID: mdl-25871846

ABSTRACT

The energy required to fuse synaptic vesicles with the plasma membrane ('activation energy') is considered a major determinant in synaptic efficacy. From reaction rate theory, we predict that a class of modulations exists, which utilize linear modulation of the energy barrier for fusion to achieve supralinear effects on the fusion rate. To test this prediction experimentally, we developed a method to assess the number of releasable vesicles, rate constants for vesicle priming, unpriming, and fusion, and the activation energy for fusion by fitting a vesicle state model to synaptic responses induced by hypertonic solutions. We show that complexinI/II deficiency or phorbol ester stimulation indeed affects responses to hypertonic solution in a supralinear manner. An additive vs multiplicative relationship between activation energy and fusion rate provides a novel explanation for previously observed non-linear effects of genetic/pharmacological perturbations on synaptic transmission and a novel interpretation of the cooperative nature of Ca(2+)-dependent release.


Subject(s)
Calcium/metabolism , Membrane Fusion/drug effects , Neurons/metabolism , Synapses/metabolism , Synaptic Transmission/drug effects , Action Potentials/drug effects , Action Potentials/physiology , Adaptor Proteins, Vesicular Transport/genetics , Adaptor Proteins, Vesicular Transport/metabolism , Animals , Biological Transport , Gene Expression , Hippocampus/cytology , Hippocampus/drug effects , Hippocampus/metabolism , Kinetics , Mice , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/cytology , Neurons/drug effects , Osmolar Concentration , Patch-Clamp Techniques , Phorbol Esters/pharmacology , Primary Cell Culture , Sucrose/pharmacology , Synapses/drug effects , Synaptic Vesicles/drug effects , Synaptic Vesicles/metabolism , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL